Targeted Therapy an ' Important Advance ' in Childhood Glioma Targeted Therapy an ' Important Advance ' in Childhood Glioma

Combining dabrafenib with trametinib markedly improved response rates and delayed progression over standard-of-care chemotherapy in pediatric BRAF V600-mutant low-grade glioma in a phase 2 trial.Medscape Medical News

Source: Medscape Hematology-Oncology Headlines - June 6, 2022 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news